BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 28861800)

  • 1. Molecular Subtyping of PrP
    Klug GM; Lewis V; Collins SJ
    Methods Mol Biol; 2017; 1658():347-354. PubMed ID: 28861800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular typing of PrPres in human sporadic CJD brain tissue.
    Lewis V; Klug GM; Hill AF; Collins SJ
    Methods Mol Biol; 2008; 459():241-7. PubMed ID: 18576159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of prion protein glycosylation in replication of human prions by protein misfolding cyclic amplification.
    Camacho MV; Telling G; Kong Q; Gambetti P; Notari S
    Lab Invest; 2019 Nov; 99(11):1741-1748. PubMed ID: 31249376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathological and biochemical criteria to identify acquired Creutzfeldt-Jakob disease among presumed sporadic cases.
    Kobayashi A; Parchi P; Yamada M; Mohri S; Kitamoto T
    Neuropathology; 2016 Jun; 36(3):305-10. PubMed ID: 26669818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease.
    Galeno R; Di Bari MA; Nonno R; Cardone F; Sbriccoli M; Graziano S; Ingrosso L; Fiorini M; Valanzano A; Pasini G; Poleggi A; Vinci R; Ladogana A; Puopolo M; Monaco S; Agrimi U; Zanusso G; Pocchiari M
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prion protein preference of sporadic Creutzfeldt-Jakob disease subtypes.
    Klemm HM; Welton JM; Masters CL; Klug GM; Boyd A; Hill AF; Collins SJ; Lawson VA
    J Biol Chem; 2012 Oct; 287(43):36465-72. PubMed ID: 22930754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycoform-selective prion formation in sporadic and familial forms of prion disease.
    Xiao X; Yuan J; Haïk S; Cali I; Zhan Y; Moudjou M; Li B; Laplanche JL; Laude H; Langeveld J; Gambetti P; Kitamoto T; Kong Q; Brandel JP; Cobb BA; Petersen RB; Zou WQ
    PLoS One; 2013; 8(3):e58786. PubMed ID: 23527023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clusterin solubility and aggregation in Creutzfeldt-Jakob disease.
    Freixes M; Puig B; Rodríguez A; Torrejón-Escribano B; Blanco R; Ferrer I
    Acta Neuropathol; 2004 Oct; 108(4):295-301. PubMed ID: 15235804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
    Moreno JA; Telling GC
    Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an Automated Capillary Immunoassay to Detect Prion Glycotypes in Creutzfeldt-Jakob Disease.
    Myskiw J; Lamoureux L; Peterson A; Knox D; Jansen GH; Coulthart MB; Booth SA
    Lab Invest; 2023 Mar; 103(3):100029. PubMed ID: 36925197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two distinct conformers of PrP
    Cali I; Espinosa JC; Nemani SK; Marin-Moreno A; Camacho MV; Aslam R; Kitamoto T; Appleby BS; Torres JM; Gambetti P
    Acta Neuropathol Commun; 2021 Mar; 9(1):55. PubMed ID: 33766126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prions from Sporadic Creutzfeldt-Jakob Disease Patients Propagate as Strain Mixtures.
    Cassard H; Huor A; Espinosa JC; Douet JY; Lugan S; Aron N; Vilette D; Delisle MB; Marín-Moreno A; Peran P; Beringue V; Torres JM; Ironside JW; Andreoletti O
    mBio; 2020 Jun; 11(3):. PubMed ID: 32546613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion diseases and emerging prion diseases.
    Yokoyama T; Mohri S
    Curr Med Chem; 2008; 15(9):912-6. PubMed ID: 18473798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular classification of sporadic Creutzfeldt-Jakob disease.
    Hill AF; Joiner S; Wadsworth JD; Sidle KC; Bell JE; Budka H; Ironside JW; Collinge J
    Brain; 2003 Jun; 126(Pt 6):1333-46. PubMed ID: 12764055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and neuropathological phenotype associated with the novel V189I mutation in the prion protein gene.
    Di Fede G; Catania M; Atzori C; Moda F; Pasquali C; Indaco A; Grisoli M; Zuffi M; Guaita MC; Testi R; Taraglio S; Sessa M; Gusmaroli G; Spinelli M; Salzano G; Legname G; Tarletti R; Godi L; Pocchiari M; Tagliavini F; Imperiale D; Giaccone G
    Acta Neuropathol Commun; 2019 Jan; 7(1):1. PubMed ID: 30606247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt-Jakob disease.
    Zou WQ; Capellari S; Parchi P; Sy MS; Gambetti P; Chen SG
    J Biol Chem; 2003 Oct; 278(42):40429-36. PubMed ID: 12917418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulating factors of PrP glycosylation in Creutzfeldt-Jakob disease--implications for the dissemination and the diagnosis of human prion strains.
    Levavasseur E; Laffont-Proust I; Morain E; Faucheux BA; Privat N; Peoc'h K; Sazdovitch V; Brandel JP; Hauw JJ; Haïk S
    PLoS One; 2008 Jul; 3(7):e2786. PubMed ID: 18665216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of sporadic Creutzfeldt-Jakob disease revisited.
    Cali I; Castellani R; Yuan J; Al-Shekhlee A; Cohen ML; Xiao X; Moleres FJ; Parchi P; Zou WQ; Gambetti P
    Brain; 2006 Sep; 129(Pt 9):2266-77. PubMed ID: 16923954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond PrP9res) type 1/type 2 dichotomy in Creutzfeldt-Jakob disease.
    Uro-Coste E; Cassard H; Simon S; Lugan S; Bilheude JM; Perret-Liaudet A; Ironside JW; Haik S; Basset-Leobon C; Lacroux C; Peoch' K; Streichenberger N; Langeveld J; Head MW; Grassi J; Hauw JJ; Schelcher F; Delisle MB; Andréoletti O
    PLoS Pathog; 2008 Mar; 4(3):e1000029. PubMed ID: 18389084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sporadic and familial CJD: classification and characterisation.
    Gambetti P; Kong Q; Zou W; Parchi P; Chen SG
    Br Med Bull; 2003; 66():213-39. PubMed ID: 14522861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.